Immunoradiometric assay of pS2 protein in breast cancer cytosolsGOUSSARD, J; LECHEVREL, C; ROUSSEL, G et al.Clinical chemistry (Baltimore, Md.). 1991, Vol 37, Num 10, pp 1759-1762, issn 0009-9147Article

Male breast cancer : clinico-pathological features, immunocytochemical characteristics and prognosisBRUCE, D. M; HEYS, S. D; PAYNE, S et al.European journal of surgical oncology. 1996, Vol 22, Num 1, pp 42-46, issn 0748-7983Article

Prognostic significance of pS2 mRNA in breast cancerWYSOCKI, S. J; IACOPETTA, B. J; INGRAM, D. M et al.European journal of cancer. Part A. 1994, Vol 30, Num 12, pp 1882-1884Article

Clinical significance of the estrogen regulated pS2 protein in mammary tumorsPICHON, M. F; MILGROM, E.Critical reviews in oncology/hematology. 1993, Vol 15, Num 1, pp 13-21, issn 1040-8428Article

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivityHARDING, C; OSUNDEKO, O; TETLOW, L et al.British journal of cancer. 2000, Vol 82, Num 2, pp 354-360, issn 0007-0920Article

Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cystsDANTE, R; RIBIERAS, S; BALDASSINI, S et al.Laboratory investigation. 1994, Vol 71, Num 2, pp 188-192, issn 0023-6837Article

Immunohistochemical survey of pS2 expression in intraductal lesions associated with invasive ductal carcinoma of the breastQINAJI, H; KOYAMA, H; MOTOMURA, K et al.International journal of cancer. 1993, Vol 55, Num 6, pp 883-886, issn 0020-7136Article

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancerCAPPELLETTI, V; CORADINI, D; SCANZIANI, E et al.European journal of cancer. Part A. 1992, Vol 28, Num 8-9, pp 1315-1318Article

Immunohistochemical determination of pS2 in invasive breast carcinomas : a study on 942 casesSOUBEYRAN, I; WAFFLART, J; BONICHON, F et al.Breast cancer research and treatment. 1995, Vol 34, Num 2, pp 119-128, issn 0167-6806Article

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancerFOEKENS, J. A; PORTENGEN, H; LOOK, M. P et al.British journal of cancer. 1994, Vol 70, Num 6, pp 1217-1223, issn 0007-0920Article

pS2 Protein status fails to be an independent prognostic factor in an average breast cancer populationSPEISER, P; STOLZLECHNER, J; HAIDER, K et al.Anticancer research. 1994, Vol 14, Num 5B, pp 2125-2130, issn 0250-7005Article

Structure primaire de la protéine humaine PS2RIO, M.-C; LEPAGE, P; DIEMUNSCH, P et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1988, Vol 307, Num 19, pp 825-831, issn 0764-4469Article

PS2 is an independent prognostic factor for post-relapse survival in primary breast cancerJANSEN, R. L. H; HUPPERETS, P. S. G. J; ARENDS, J. W et al.Anticancer research. 1998, Vol 18, Num 1B, pp 577-582, issn 0250-7005Article

Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosaMACHADO, J.-C; CARNEIRO, F; BLIN, N et al.European journal of cancer prevention. 1996, Vol 5, Num 3, pp 169-179, issn 0959-8278Article

Papillomatous melanocytic nevi : an estrogen related phenomenonMORGAN, M. B; RALEY, B. A; VANNARATH, R. L et al.Journal of cutaneous pathology. 1995, Vol 22, Num 5, pp 446-449, issn 0303-6987Article

Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activityCORREALE, M; PARADISO, A; ABBATE, I et al.Tumor biology. 1993, Vol 14, Num 1, pp 30-37, issn 1010-4283Article

pS2 protein in gastric carcinoma and normal gastric mucosa : association with clinicopathological parameters and patient survivalMÜLLER, W; BORCHARD, F.Journal of pathology. 1993, Vol 171, Num 4, pp 263-269, issn 0022-3417Article

pS2 protein and steroid hormone receptors in invasive breast carcinomasKOERNER, F. C; GOLDBERG, D. E; EDGERTON, S. M et al.International journal of cancer. 1992, Vol 52, Num 2, pp 183-188, issn 0020-7136Article

Prognostic significance of cytosolic pS2 protein content in gastric cancerSUAREZ, C; VIZOSO, F; RODRIGUEZ, J. C et al.The International journal of biological markers. 2001, Vol 16, Num 1, pp 37-44, issn 0393-6155Article

Expression of the pS2 peptide in primary breast carcinomas : comparison of membrane and cytoplasmic staining patternsDOOKERAN, K. A; RYE, P. D; DEARING, S. J et al.Journal of pathology. 1993, Vol 171, Num 2, pp 123-129, issn 0022-3417Article

The bovine pancreatic spasmolytic polypeptide gene maps to syntenic group U10 : implications for the evolution of the human breast cancer estrogen inducible locusTHREADGILL, D. S; WOMACK, J. E.The journal of heredity. 1991, Vol 82, Num 6, pp 496-498, issn 0022-1503Article

Expression of a breast-cancer-associated protein (pS2) in human neuro-endocrine tumoursWANG, D.-G; JOHNSTON, C. F; LIU, W.-H et al.International journal of cancer. 1997, Vol 74, Num 3, pp 270-274, issn 0020-7136Article

pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric studyMACHADO, J.-C; CARNEIRO, F; RIBEIRO, P et al.European journal of cancer (1990). 1996, Vol 32, Num 9, pp 1585-1590, issn 0959-8049Article

Correlation of pS2 expression of involved lymph nodes in relation to primary breast carcinomaNICHOLS, P. H; IBRAHIM, N. B. N; PADFIELD, J. H et al.European journal of surgical oncology. 1995, Vol 21, Num 2, pp 151-154, issn 0748-7983Article

High positive rate of pS2 expression in forefront intraductal cancerous area in breast cancerYAMAKAWA, T; MORIMOTO, T; SASA, M et al.Japanese journal of cancer research. 1995, Vol 86, Num 11, pp 1035-1040, issn 0910-5050Article